These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 15082751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier.
    Monnaert V, Betbeder D, Fenart L, Bricout H, Lenfant AM, Landry C, Cecchelli R, Monflier E, Tilloy S.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1115-20. PubMed ID: 15280439
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier.
    Tilloy S, Monnaert V, Fenart L, Bricout H, Cecchelli R, Monflier E.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2154-7. PubMed ID: 16464592
    [Abstract] [Full Text] [Related]

  • 8. Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model.
    Balazs Z, Panzenboeck U, Hammer A, Sovic A, Quehenberger O, Malle E, Sattler W.
    J Neurochem; 2004 May 15; 89(4):939-50. PubMed ID: 15140193
    [Abstract] [Full Text] [Related]

  • 9. How cyclodextrins can mask their toxic effect on the blood-brain barrier.
    Binkowski-Machut C, Hapiot F, Martin P, Cecchelli R, Monflier E.
    Bioorg Med Chem Lett; 2006 Apr 01; 16(7):1784-7. PubMed ID: 16442287
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
    Bikádi Z, Kurdi R, Balogh S, Szemán J, Hazai E.
    Chem Biodivers; 2006 Nov 01; 3(11):1266-78. PubMed ID: 17193241
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
    Silwedel C, Förster C.
    J Neuroimmunol; 2006 Oct 01; 179(1-2):37-45. PubMed ID: 16884785
    [Abstract] [Full Text] [Related]

  • 17. Lysozyme refolding with cyclodextrins: structure-activity relationship.
    Desai A, Lee C, Sharma L, Sharma A.
    Biochimie; 2006 Oct 01; 88(10):1435-45. PubMed ID: 16737767
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution.
    Abulrob A, Tauskela JS, Mealing G, Brunette E, Faid K, Stanimirovic D.
    J Neurochem; 2005 Mar 01; 92(6):1477-86. PubMed ID: 15748165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.